DekaBank Deutsche Girozentrale - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 136 filers reported holding REVANCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,012
-52.8%
86,1000.0%0.00%
-60.0%
Q2 2023$2,142
-19.4%
86,1000.0%0.01%
-28.6%
Q1 2023$2,657
+66.2%
86,1000.0%0.01%
+75.0%
Q4 2022$1,599
-99.9%
86,1000.0%0.00%
-42.9%
Q3 2022$2,209,000
+81.8%
86,1000.0%0.01%
+75.0%
Q2 2022$1,215,000
+139.6%
86,100
+229.9%
0.00%
+300.0%
Q1 2022$507,000
+8.3%
26,100
-7.4%
0.00%0.0%
Q4 2021$468,000
-75.1%
28,200
-58.3%
0.00%
-80.0%
Q3 2021$1,880,000
-4.7%
67,6000.0%0.01%
-16.7%
Q2 2021$1,972,000
+6.1%
67,6000.0%0.01%0.0%
Q1 2021$1,859,000
+8.8%
67,600
+7.1%
0.01%0.0%
Q4 2020$1,708,000
+47.0%
63,100
+36.3%
0.01%
+20.0%
Q3 2020$1,162,000
+111.3%
46,300
+15.8%
0.01%
+66.7%
Q3 2019$550,000
-45.5%
40,000
-50.0%
0.00%
-40.0%
Q2 2019$1,010,000
+19.2%
80,000
+183.7%
0.01%
-16.7%
Q1 2018$847,000
+254.4%
28,200
+107.4%
0.01%
+100.0%
Q1 2016$239,000
-51.9%
13,600
-2.9%
0.00%
-50.0%
Q4 2015$497,000
+39.2%
14,000
+16.7%
0.01%
+50.0%
Q3 2015$357,000
-3.0%
12,000
+4.3%
0.00%0.0%
Q2 2015$368,000
+60.0%
11,500
+3.6%
0.00%
+33.3%
Q1 2015$230,00011,1000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,415,689$86,106,0006.66%
Evolutionary Tree Capital Management, LLC 176,336$3,439,0002.39%
Essex Woodlands Management, Inc. 457,085$8,913,0002.16%
HealthCor Management, L.P. 1,423,425$27,757,0001.85%
RICE HALL JAMES & ASSOCIATES, LLC 1,112,325$21,690,0000.86%
Waypoint Capital Advisors, LLC 53,989$1,016,0000.60%
Antara Capital LP 679,600$13,252,0000.40%
Rhenman & Partners Asset Management AB 198,358$3,868,0000.38%
Walleye Capital LLC 505,701$9,861,0000.26%
Polar Capital Holdings Plc 2,456,497$47,902,0000.22%
View complete list of REVANCE THERAPEUTICS INC shareholders